Background: Common genetic polymorphisms at chromosome 4q25 were associated with increased
Introduction
Atrial fibrillation (AF) is one of the most prevalent forms of cardiac dysrhythmia in clinical practice, which affects 33.5 million individuals globally [1] . Several factors already have been identified to increase the susceptibility to AF, such as smoking, sex, and obesity [2] [3] [4] . Interestingly, genetic predisposition has been added into the long list of risk factors for AF. Gudbjartsson et al. found common genetic polymorphisms at chromosome 4q25 (PITX2) locus, including rs2200733 C>T (at-risk allele T) and rs10033464 G>T (at-risk allele T), were associated with increased susceptibility to AF [5] . The association between rs2200733 and AF was further replicated in Indian [6] , Spanish [7] , Danish [8] , Italian [9] and Polish [10] as well as Chinese populations [11] . Three different genotypes, CC, CT and TT were identified in rs2200733 with minor allele frequency 0.21 to 0.39 across different ethnic groups [12, 13] . The prevalence of rs10033464 G>T was reported from 19% to 32% predisposed to AF recurrence after ablation [14, 15] . Several genetic models, including allelic (T vs. C for rs2200733, T vs. G for rs10033464), heterozygous (TC vs. CC for rs2200733, TG vs. GG for rs10033464), homozygous (TT vs. CC for rs2200733, TT vs. GG for rs10033464), dominant (TT+TC vs. CC for rs2200733, TT+TG vs. GG for rs10033464), recessive (TT vs. TC+CC for rs2200733, TT vs. TG+GG for rs10033464) models were applied to quantify the association between rs2200733/rs10033464 and AF recurrence after ablation [10, 15, 16] . However, the relationship between two common polymorphisms (rs2200733 C>T and rs10033464 G>T) at chromosome 4q25 locus and AF recurrence after catheter ablation remained controversial.
Husser et al. [15] provided evidence that the presence of any variant allele (rs2200733 T or rs10033464 T) increased the risk of AF recurrence within the first 7 days and between 3 and 6 months in Caucasian patients of German descent. And both variants independently predicted AF recurrence when evaluated by dominant models in multivariable analysis [15] . In Chinese Han population, single nucleotide polymorphism (SNP) rs2200733 was an independent factor for AF recurrence after ablation, and the risk allele T was associated with AF recurrence [17] . Zhao et al. [16] also reported rs2200733 TT was able to predict a 1.8-fold increased risk for clinical recurrence after catheter ablation. On the contrary, Kiliszek et al. [18] found that rs2200733 C>T or rs10033464 G>T failed to correlate with AF recurrence after a single AF ablation in long-term follow-up (median of 45 months). In Korean patients, rs2200733 T allele was strongly associated with AF, but this SNP again failed to predict clinical recurrence after catheter ablation [12] . Therefore, the present study performed a meta-analysis to investigate the effect of common non-coding variants on chromosome 4q25 (rs2200733 C>T and rs10033464 G>T) on the risk of AF recurrence after catheter ablation.
Methods

Literature search
A systematic search of PubMed, Web of science, Elsevier database and Cochrane library was undertaken for studies through November 2016. The search terms included all possible combinations "rs2200733", "rs10033464", "SNP", "polymorphism or variant", "atrial fibrillation", "AF", "4q25 (PITX2)", "ablation", "outcome", and "AF recurrence after ablation". Manual searches of study references were also conducted. Moreover, several related articles from reviews and other pertinent sources such as research bibliographies were inspected as well.
Inclusion and exclusion criteria
An initial screening for titles and abstracts was performed. A second screening was based on full-text review. The following criteria were used to evaluate whether a study was eligible:
a) The association between rs2200733/rs10033464 and AF recurrence after ablation must be assessable.
b) The genotype data of rs2200733 and rs10033464 must be provided.
c) The study has a cohort design or has a case-control.
d) The research should report an estimate of risk for AF recurrence after ablation with a corresponding 95% confidence interval (CI). e) If the same population was studied in more than one study, study with larger sample size and more comprehensive outcome were included. f) AF recurrence was defined according to the Heart Rhythm Society/European Heart Rhythm Association/European Cardiac Arrhythmia Society Consensus Statement recommendations. Late recurrence of AF (LRAF) was defined as any episode of atrial tachyarrhythmia, including atrial tachycardia, atrial flutter, or AF (AT/AF) lasting more than 30 s that occurred after a 3-month post-ablation blanking period. Early recurrence of AF (ERAF) was defined as an AF episode within 3 months, post-ablation blanking period.
Studies were excluded if they met the following criteria:
a) It is a review, letter, conference abstracts, and/or case report.
b) The study lacked information on the risk of AF recurrence after ablation.
c) The study did not provide sufficient data.
Data extraction and quality assessment
An outcome of interest in this study was the capability of rs2200733 and rs10033464 to predict the risk of AF recurrence after catheter ablation. After careful review, data was extracted using a standardized data-collection form for each eligible article: first, author name, publication year, ethnicity/nationality, patient number, patient characteristics. Clinical end point and quality assessment, comorbid conditions, anatomic factors, ablation strategies, methods of AF recurrence ascertainment, and adjunctive post-operation therapy were also considered. The quality of each study was evaluated according to the Newcastle-Ottawa quality assessment scale (NOS) [19] .
Statistical analyses
All statistical analyses were performed with Stata 12.0 software (StataCorp, College Station, TX, USA). Odds ratio (OR) was used as a common measure of the association between rs2200733 C>T/ rs10033464 G>T and AF recurrence. Pooled ORs were performed for allelic comparison (T vs 
Results
Study characteristics
A total of 32 records were identified through the above mentioned literature search strategy. After screening titles and abstracts in the first round, 12 articles were excluded. Following this, the remaining 20 articles, 7 articles were excluded that did not involve AF recurrence, rs2200733 or rs10033464. After reviewing full texts and data, 8 articles were excluded (5 articles without sufficient information on risk estimate, and 3 articles without ablation). Finally, 5 articles were eligible for inclusion in this study. Husser et al. [15] reported ORs for both ERAF and LRAF; each OR was included in this analysis. A total of 2,145 patients who underwent catheter ablation were included. The characteristics of the included studies were presented in Table 1 and in supplemental information Table 2 . The NOS scores of included studies were all more than 7 scores (high quality).
In general, AF ablation strategy was comparable among included studies. A 3-dimensional mapping system was used for catheter orientation, computed tomographic image integration, and tagging of the ablation sites (NavX /NavX-Ensite system [12, 15] ; or CARTO system [16, 17] ; or LocaLisa system [18] ). Transseptal access was performed. And an irrigated-tip ablation catheter was used in 4 studies [12, [15] [16] [17] . A non-irrigated catheter was used in one study [18] under the consideration of non-significant difference in AF recurrence between patients treated with irrigated and non-irrigated catheters [20] . Circumferential pulmonary vein isolation (CPVI) with bidirectional block was a major ablation endpoint at all centers. Additional ablation to the left atrial (LA) roof, basal posterior wall, posterior inferior wall, and anterior wall, mitral isthmus, cavotricuspid isthmus, superior vena cava, non-PV foci, complex fractionated atrial electrograms (CFAEs) were performed based on operator discretion.
Genotypic association between rs2200733 C>T and AF recurrence
In the primary analysis, the associations between rs2200733 C>T and AF recurrence after ablation were analyzed under five genetic models (Table 3) . 
Genotypic association between rs10033464 G>T and AF recurrence
In the secondary analysis, the associations between rs10033464 G>T and the risk of AF recurrence were evaluated. A significant increased risk of AF recurrence was identified in the allelic 
Sensitivity analysis and publication bias
Sensitivity analysis was performed to evaluate the influence of single study on the pooled ORs for rs2200733 C>T and rs10033464 G>T by deleting each study once in every genetic model.
Consistently, the pooled estimate remained nonsignificant. No publication bias for the association between rs2200733 C>T and AF susceptibility was identified by Begg's funnel plot (p = 0.133; Table   3 ) or Egger's regression test (p = 0.075; Table 3 ). Symmetrical funnel plots were obtained in all five genetic models. Due to limited studies, no funnel plot or Egger tests were performed for the association between rs10033464 G>T and the risk of AF recurrence after ablation.
Discussion
Catheter ablation has been employed as a first-line treatment for rhythm control in many patients In this meta-analysis, carriers of at least 1 risk allele conferred an increased risk of 41% or 51% for AF recurrence when evaluated by dominant model for rs2200733 or rs10033464, respectively.
However, the mechanisms underlying these associations remained elusive. These noncoding variants existed in close proximity (~150 kb) to the cis-regulatory region of paired-like homeodomain transcription factor 2 (PITX2), and modulated PITX2 activity through transcription level as whether re-ablations were performed or not has remained unknown during the follow-up period in these centers, reconduction could not be assessed. AF recurrences might be due to different mechanisms that are not captured with the analyzed variants in these studies. And it is also worth noting that 4q25 variants may simply be used as one of the clinical markers for outcome prediction. AF -atrial fibrillation; HWE -Hardy-Weinberg equilibrium; ERAF -early recurrence of AF within 3-month post-ablation blanking period; LRAF -late recurrence of AF after 3-month post-ablation blanking period; NR -not reported 
